🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I/safety dose expansion study of the combination of the dru...
Status
Terminated
Location
Georgetown Lombardi Comprehensive Cancer Center
Start Date
2014-10
Trial ID
NCT02261805
Treatments Being Tested
This pilot clinical trial studies how well ganetespib works before surgery ...
Status
Terminated
Location
Emory University Hospital Midtown
Start Date
2014-12
Trial ID
NCT02334319
Treatments Being Tested
RATIONALE: Heat shock protein (HSP)90 inhibitor STA-9090 may stop the growt...
Status
Terminated
Location
The Jones Clinic
Start Date
2010-12
Trial ID
NCT01227018
Treatments Being Tested
The AML18 Pilot Trial will evaluate the feasibility of three interventions ...
Status
Completed
Location
Aberdeen Royal Infirmary
Start Date
2011-04
Trial ID
NCT01236144
Treatments Being Tested
This is an open-label, Phase 1, dose-escalation study to determine the reco...
Status
Completed
Location
Emory University School of Medicine
Start Date
2010-07
Trial ID
NCT01183364
Treatments Being Tested
The purpose of this study is to determine if STA-9090 is effective in the t...
Status
Completed
Location
UCLA Medical Center
Start Date
2010-01
Trial ID
NCT01039519
Treatments Being Tested
The purpose of this study is to determine if ganetespib (STA-9090) is effec...
Status
Completed
Location
Synta Pharmaceuticals Investigative Site
Start Date
2012-07
Trial ID
NCT01677455
Treatments Being Tested
The purpose of this study is to characterize the safety and efficacy of STA...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00858572
Treatments Being Tested
Based on preclinical data implicating GR, AR, and JAK/STAT activation as po...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-05
Trial ID
NCT02637375
Treatments Being Tested
This phase I trial studies the side effects and best dose of ganetespib whe...
Status
Completed
Location
NYU Cancer Institute
Start Date
2014-04
Trial ID
NCT02060253
Treatments Being Tested